From July 1, 2022 to August 18, 2022, the company has repurchased 0 shares, representing 0% for KRW 0 million. With this, the company has completed the repurchase of 227,719 shares, representing 3.24% for KRW 3,718.7 million under the buyback announced on February 18, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13,250 KRW | +0.91% |
|
+2.71% | +18.09% |
1st Jan change | Capi. | |
---|---|---|
+18.09% | 64.91M | |
+15.58% | 121B | |
+16.60% | 110B | |
+17.73% | 25.93B | |
-24.33% | 19.27B | |
-19.35% | 16.01B | |
-17.95% | 15.66B | |
-48.32% | 14.89B | |
+58.78% | 14.47B | |
+4.91% | 13.91B |
- Stock Market
- Equities
- A049960 Stock
- News Cell Biotech Co., Ltd.
- Tranche Update on Cell Biotech Co., Ltd.'s Equity Buyback Plan announced on February 18, 2022.